Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements
International Journal of Cancer · 2023
DOI: 10.1002/ijc.34416 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Kari Hemminki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center and Faculty of Medicine, Pilsen, Charles University in Prague, Pilsen, Czech Republic. Hauptthemen laut MEDLINE: Neoplasms, Testicular Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Survival studies are an important indicator of the success of cancer control. We analyzed the 5‐year relative survival in 23 solid cancers in Denmark, Finland, Norway and Sweden over a 50‐year period (1970‐2019) at the NORDCAN database accessed from the International Agency for Research on Cancer website. We plotted survival curves in 5‐year periods and showed 5‐year periodic survival. The survival results were summarized in four groups: (1) cancers with historically good survival (>50% in 1970‐1974) which include melanoma and breast, endometrial and thyroid cancers; (2) cancers which constantly improved survival at least 20% units over the 50 year period, including cancers of the stomach, colon, rectum, kidney, brain and ovary; (3) cancer with increase in survival >20% units with changes taking place in a narrow time window, including oral, oropharyngeal, testicular and prostate cancers; (4) the remaining cancers with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Center and Faculty of Medicine, Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
- Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
- Department of Surgery, University Hospital Pilsen, Charles University, Pilsen, Czech Republic.
- Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Kari Hemminki, Akseli Hemminki
Zitieren
APA
Hemminki, K., Försti, A., Liska, V., Kanerva, A., Hemminki, O., & Hemminki, A. (2023). Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements. International Journal of Cancer. https://doi.org/10.1002/ijc.34416
Vancouver
Hemminki K, Försti A, Liska V, Kanerva A, Hemminki O, Hemminki A. Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements. International Journal of Cancer. 2023. doi:10.1002/ijc.34416
BibTeX
@article{Hemminki2023,
author = {Hemminki, Kari and Försti, Asta and Liska, Vaclav and Kanerva, Anna and Hemminki, Otto and Hemminki, Akseli},
title = {Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements},
journal = {International Journal of Cancer},
year = {2023},
doi = {10.1002/ijc.34416}
}
EUVIMED